Diabetes mellitus is a disease of large magnitude with 25 million people affected by the disease in India. One of the common complications of this
disease is Diabetic foot disease characterised by non-healing ulcers over the foot predominantly. This study is aimed at evaluating the efcacy and
tolerability of Recombinant Epidermal Growth Factor treatment in increasing the rate of healing of ulcers and decreasing the duration of ulcer
healing among patients with diabetic foot disease thereby improving the quality of life, preventing further morbidity and mortality and shortening
hospital stay.